H.B. 30 Enrolled

             1     

CONTROLLED SUBSTANCES AMENDMENTS

             2     
2014 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Chief Sponsor: Paul Ray

             5     
Senate Sponsor: Allen M. Christensen

             6     
             7      LONG TITLE
             8      General Description:
             9          This bill modifies Title 58, Chapter 37, Utah Controlled Substances Act, by adding
             10      controlled substances.
             11      Highlighted Provisions:
             12          This bill:
             13          .    adds new "spice" and emerging drug analogs to the listed controlled substances.
             14      Money Appropriated in this Bill:
             15          None
             16      Other Special Clauses:
             17          This bill provides an immediate effective date.
             18      Utah Code Sections Affected:
             19      AMENDS:
             20           58-37-4.2 , as last amended by Laws of Utah 2013, Chapters 83 and 88
             21     
             22      Be it enacted by the Legislature of the state of Utah:
             23          Section 1. Section 58-37-4.2 is amended to read:
             24           58-37-4.2. Listed controlled substances.
             25          The following substances, their analogs, homologs, and synthetic equivalents are listed
             26      controlled substances:
             27          (1) AB-001;
             28          (2) AB-PINACA;
             29      N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;


             30          (3) AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)
             31      methyl]-1H-indazole-3-carboxamide;
             32          [(2)] (4) AKB48;
             33          [(3)] (5) alpha-Pyrrolidinovalerophenone (alpha-PVP);
             34          [(4)] (6) AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;
             35          [(5)] (7) AM-1248;
             36          [(6)] (8) AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;
             37          [(7)] (9) AM-2233;
             38          [(8)] (10) AM-679;
             39          [(9)] (11) A796,260;
             40          [(10)] (12) Butylone;
             41          [(11)] (13) CP 47,497 and its C6, C8, and C9 homologs;
             42      2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol;
             43          [(12)] (14) Diisopropyltryptamine (DiPT);
             44          [(13)] (15) Ethylone;
             45          [(14)] (16) Ethylphenidate;
             46          [(15)] (17) Fluoroisocathinone;
             47          [(16)] (18) Fluoromethamphetamine;
             48          [(17)] (19) Fluoromethcathinone;
             49          [(18)] (20) HU-210;
             50      (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
             51      -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
             52          [(19)] (21) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
             53      methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
             54          [(20)] (22) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
             55          [(21)] (23) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as
             56      1-Pentyl-3-(1-naphthoyl)indole};
             57          [(22)] (24) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;


             58          [(23)] (25) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
             59      1-Butyl-3-(1-naphthoyl)indole};
             60          [(24)] (26) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
             61          [(25)] (27) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
             62          [(26)] (28) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;
             63          [(27)] (29) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
             64          [(28)] (30) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
             65          [(29)] (31) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
             66          [(30)] (32) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
             67          [(31)] (33) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;
             68          [(32)] (34) MAM-2201;
             69          (35) MAM-2201;
             70      (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;
             71          [(33)] (36) Methoxetamine;
             72          [(34)] (37) Naphyrone;
             73          (38) PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;
             74          [(35)] (39) Pentedrone;
             75          [(36)] (40) Pentylone;
             76          [(37)] (41) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
             77          [(38)] (42) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
             78      known as BTW-8 and SR-18};
             79          [(39)] (43) STS-135;
             80          [(40)] (44) UR-144;
             81          [(41)] (45) UR-144 N-(5-chloropentyl) analog;
             82          [(42)] (46) XLR11;
             83          [(43)] (47) 2C-C;
             84          [(44)] (48) 2C-D;
             85          [(45)] (49) 2C-E;


             86          [(46)] (50) 2C-H;
             87          [(47)] (51) 2C-I;
             88          [(48)] (52) 2C-N;
             89          [(49)] (53) 2C-P;
             90          [(50)] (54) 2C-T-2;
             91          [(51)] (55) 2C-T-4;
             92          [(52)] (56) 2NE1;
             93          [(53)] (57) 25I-NBOMe;
             94          [(54)] (58) 2,5-Dimethoxy-4-chloroamphetamine (DOC);
             95          [(55)] (59) 4-methylmethcathinone {also known as mephedrone};
             96          [(56)] (60) 3,4-methylenedioxypyrovalerone {also known as MDPV};
             97          [(57)] (61) 3,4-Methylenedioxymethcathinone {also known as methylone};
             98          [(58)] (62) 4-methoxymethcathinone;
             99          [(59)] (63) 4-Methyl-alpha-pyrrolidinopropiophenone;
             100          [(60)] (64) 4-Methylethcathinone;
             101          [(61)] (65) 5F-AKB48;
             102      1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;
             103          (66) 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl
             104      ester;
             105          [(62)] (67) 5-Iodo-2-aminoindane (5-IAI);
             106          [(63)] (68) 5-MeO-DALT;
             107          [(64)] (69) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
             108      methyl]ethanamine; [and]
             109          [(65)] (70) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
             110      methyl]ethanamine[.]; and
             111          (71) 25H-NBOMe;
             112      2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.
             113          Section 2. Effective date.


             114          If approved by two-thirds of all the members elected to each house, this bill takes effect
             115      upon approval by the governor, or the day following the constitutional time limit of Utah
             116      Constitution, Article VII, Section 8, without the governor's signature, or in the case of a veto,
             117      the date of veto override.


[Bill Documents][Bills Directory]